跳至主要内容
临床试验/NCT03204201
NCT03204201终止1 期

Validation of ICG to Identify the Urethra During Rectal Surgery

Oxford University Hospitals NHS Trust1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2017年7月11日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
终止
入组人数
5
试验地点
1
主要终点
Number of urethras identified under white light and fluorescence

研究概览

简要总结

This is an open-label feasibility study utilising direct instillation of ICG into the urethra during surgery for low rectal cancers. The trial involves a single intervention taking place during the patient's operation. Participants will be included in the study for around 2 months with time either side of the intervention to collect background data.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Participant is willing and able to give informed consent for participation in the study.
  • Male, aged 18 years or above.
  • Undergoing low rectal surgery where the operating field will be close to the urethra

排除标准

  • Participant has an allergy to iodine or ICG
  • Known liver failure

研究组 & 干预措施

Urethral instillation of ICG

Experimental

Urethral instillation of indocyanine green (ICG)

干预措施: Indocyanine Green Solution (Drug)

结局指标

主要结局

Number of urethras identified under white light and fluorescence

时间窗: 1 day

次要结局

  • Signal to background ratios between cohorts of patients with varying doses of ICG(1 day)
  • Subjective assessment of usefulness of technology during operative procedure(1 day)
  • Length of time of interruption in operative procedure to perform trial intervention(1 day)
  • Number of adverse events related to trial intervention(30 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Thomas Barnes

Clinical Research Fellow

Oxford University Hospitals NHS Trust

研究点 (1)

Loading locations...

相似试验

Validation of ICG to Identify the Urethra During... | 临床试验